Trump's generic drugs tariff threatens Indian pharma's top market
--------------------------------------------------------------------
Source: Nikkei Asia
Published: 2026-07-22 21:22 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Science, Economy & Finance, Financial Markets, India, Trade & Sanctions, Drugs, World News, US Politics, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
The U.S. accounted for about 37% of India's nearly $26 billion in pharma exports in 2025, the Global Trade Research Initiative estimates. © Reuters
--------------------------------------------------------------------